SCHEMBL23787553

SCHEMBL23787553

Cc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4ccc(N)cc4c3O)c(C)c2)ccc1/N=N/c1c(S(=O)(=O)O)cc2cc(N)ccc2c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHLPP2 Q6ZVD8 2/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ HTT P42858 1/20 0.61
▸ SUMO2 P61956 2/20 0.58
▸ SUMO1 P63165 2/20 0.58
▸ SENP7 Q9BQF6 2/20 0.58
▸ SENP2 Q9HC62 2/20 0.58
▸ SENP3 Q9H4L4 1/20 0.58
▸ SENP1 Q9P0U3 1/20 0.58
▸ ALDH1A1 P00352 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ APP P05067 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ HPGD P15428 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787554 0.89 PHLPP2 (0.53) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787555 0.88 PHLPP2 (0.60) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787646 0.88 PHLPP2 (0.59) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787647 0.88 PHLPP2 (0.59) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787588 0.87 PHLPP2 (0.80) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787648 0.87 PHLPP2 (0.59) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787696 0.85 PHLPP2 (0.57) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787797 0.85 PHLPP2 (0.56) PHLPP2MEN1KMT2AHTTSUMO2
SCHEMBL23787739 0.85 ENPP2 (0.61) PHLPP2MEN1KMT2AALDH1A1APP
SCHEMBL8958917 0.84 PHLPP2 (0.56) PHLPP2MEN1KMT2AHTTSUMO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 PHLPP2 1195/4885MEN1 2015/4885KMT2A 1402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback